SCHEMBL2571504

SCHEMBL2571504

O=C(CS)OCCCCC(COC(=O)CS)OC(=O)CS

nearest known ligand 0.37

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
PRKCA P17252 2/20 0.34
PRKCE Q02156 2/20 0.34
PRKCQ Q04759 2/20 0.34
PRKCD Q05655 2/20 0.34
NAAA Q02083 1/20 0.32
LPAR3 Q9UBY5 6/20 0.31
LPAR1 Q92633 4/20 0.31
ENPP2 Q13822 3/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
FABP3 P05413 1/20 0.30
LPAR2 Q9HBW0 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11587751 0.86 PRKCA (0.37) ALDH1A1LMNAPRKCAPRKCEPRKCQ
SCHEMBL97661 0.81 ALDH1A1 (0.46) ALDH1A1LMNAPRKCAPRKCEPRKCQ
SCHEMBL331612 0.77 ALDH1A1 (0.39) ALDH1A1LMNAPRKCAPRKCEPRKCQ
SCHEMBL31651034 0.77 ALDH1A1 (0.38) ALDH1A1LMNAPRKCAPRKCEPRKCQ
SCHEMBL60931 0.77 NAAA (0.46) ALDH1A1NAAA
SCHEMBL332068 0.76 PRKCA (0.53) PRKCAPRKCEPRKCQPRKCD
SCHEMBL15512750 0.76 ALDH1A1 (0.51) ALDH1A1LMNAPRKCAPRKCEPRKCQ
SCHEMBL11585668 0.74 NAAA (0.50) ALDH1A1NAAA
SCHEMBL97045 0.74 NAAA (0.50) ALDH1A1NAAA
SCHEMBL11235417 0.74 NAAA (0.50) ALDH1A1NAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1606320-B1 CROSSLINKED THREE-DIMENSIONAL POLYMER NETWORK, METHOD FOR PREPARING SAME, SUPPORT MATERIAL COMPRISING SAME AND USES THEREOF CHIROSEP (FR) 2007-06-13 EP claimed
EP-1427525-A2 CROSSLINKED THREE-DIMENSIONAL POLYMER NETWORK, METHOD FOR PREPARING SAME, SUPPORT MATERIAL COMPRISING SAME AND USES THEREOF Chirosep (FR) 2004-06-16 EP claimed
WO-2003026793-A2 CROSSLINKED THREE-DIMENSIONAL POLYMER NETWORK, METHOD FOR PREPARING SAME, SUPPORT MATERIAL COMPRISING SAME AND USES THEREOF EKA CHEMICALS AB (SE) 2003-04-03 WO claimed
EP-4705103-A2 EPOXY RESIN COMPOSITIONS, COMPOSITE MATERIALS, AND METHODS OF COATING SUBSTRATES Westlake Epoxy Inc. (US) 2026-03-11 EP disclosed
US-20260005023-A1 METHODS FOR FABRICATING SEMICONDUCTOR DEVICES AND RESIST COMPOSITIONS FOR UNDERLAYERS USED THEREFOR SAMSUNG ELECTRONICS CO LTD (KR) 2026-01-01 US disclosed
US-20250250433-A1 EPOXY RESIN COMPOSITIONS AND USES THEREOF Westlake Epoxy Inc. 2025-08-07 US disclosed
US-20240360335-A1 EPOXY RESIN COMPOSITIONS, COMPOSITE MATERIALS, AND METHODS OF COATING SUBSTRATES Westlake Epoxy Inc. 2024-10-31 US disclosed
WO-2024226320-A2 EPOXY RESIN COMPOSITIONS, COMPOSITE MATERIALS, AND METHODS OF COATING SUBSTRATES Westlake Epoxy Inc. (US) 2024-10-31 WO disclosed
CN-118019780-A Polyimide, polyimide precursor, composition, and method for producing polyimide 富士胶片株式会社 2024-05-10 CN disclosed
EP-3681960-B1 SILICONE 3D PRINTING INK ETH ZUERICH (CH) 2024-02-14 EP disclosed
US-20240002603-A1 ACTIVE ENERGY RAY-CURABLE COMPOSITION WITH DARK PART CURABILITY TOAGOSEI CO., LTD. (JP) 2024-01-04 US disclosed
WO-2010078449-A2 COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS ARDELYX, INC. (US) 2010-07-08 WO disclosed
US-7745656-B2 Stable no-delivering compounds DUKE UNIVERSITY (US) 2010-06-29 US disclosed
US-7745656-B2 Stable no-delivering compounds DUKE UNIVERSITY (US) 2010-06-29 US disclosed
US-7417109-B2 Polymers for delivering nitric oxide in vivo DUKE UNIVERSITY (US) 2008-08-26 US disclosed
US-7417109-B2 Polymers for delivering nitric oxide in vivo DUKE UNIVERSITY (US) 2008-08-26 US disclosed
US-20070088435-A1 Novel polymers for delivering nitric oxide in vivo STAMLER JONATHAN S 2007-04-19 US disclosed
US-20070088435-A1 Novel polymers for delivering nitric oxide in vivo STAMLER JONATHAN S 2007-04-19 US disclosed
EP-0730011-B1 Scratch-resistant, UV-curable coating containing a copolymerizable thickener ROEHM GMBH (DE) 1998-12-09 EP disclosed
EP-0730011-A1 Scratch-resistant, UV-curable coating containing a copolymerizable thickener RÖHM GMBH (DE) 1996-09-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260005023-A1 METHODS FOR FABRICATING SEMICONDUCTOR DEVICES AND RESIST COMPOSITIONS FOR UNDERLAYERS USED THEREFOR BMI1, SETD7, SETDB1 ALDH1A1 1115/4885LMNA 4313/4885PRKCA 3292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.